tiprankstipranks
FibroGen options imply 18.1% move in share price post-earnings
PremiumThe FlyFibroGen options imply 18.1% move in share price post-earnings
9d ago
Options Volatility and Implied Earnings Moves Today, March 17, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 17, 2025
9d ago
Is FGEN a Buy, Before Earnings?
Premium
Pre-Earnings
Is FGEN a Buy, Before Earnings?
25d ago
FibroGen selling FibroGen China to AstraZeneca for $160M
PremiumThe FlyFibroGen selling FibroGen China to AstraZeneca for $160M
1M ago
Perspective Therapeutics appoints Graham as CFO
Premium
The Fly
Perspective Therapeutics appoints Graham as CFO
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
FGEN Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsFGEN Upcoming Earnings Report: What to Expect?
5M ago
Disc Medicine appoints Kaushik as Chief Technical Officer
Premium
The Fly
Disc Medicine appoints Kaushik as Chief Technical Officer
5M ago
FibroGen Cuts Costs by Terminating San Francisco Lease Early
Premium
Company Announcements
FibroGen Cuts Costs by Terminating San Francisco Lease Early
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100